Free Trial
NYSE:NUVB

Nuvation Bio (NUVB) Stock Price, News & Analysis

Nuvation Bio logo
$2.24 +0.12 (+5.40%)
Closing price 03:59 PM Eastern
Extended Trading
$2.26 +0.01 (+0.45%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nuvation Bio Stock (NYSE:NUVB)

Key Stats

Today's Range
$2.15
$2.29
50-Day Range
$1.73
$2.53
52-Week Range
$1.54
$3.97
Volume
4.20 million shs
Average Volume
4.19 million shs
Market Capitalization
$763.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.17
Consensus Rating
Buy

Company Overview

Nuvation Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

NUVB MarketRank™: 

Nuvation Bio scored higher than 62% of companies evaluated by MarketBeat, and ranked 383rd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nuvation Bio has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nuvation Bio has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Nuvation Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Nuvation Bio are expected to decrease in the coming year, from ($0.36) to ($0.64) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuvation Bio is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuvation Bio is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nuvation Bio has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nuvation Bio's valuation and earnings.
  • Percentage of Shares Shorted

    29.08% of the float of Nuvation Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvation Bio has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Nuvation Bio has recently increased by 17.24%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nuvation Bio does not currently pay a dividend.

  • Dividend Growth

    Nuvation Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    29.08% of the float of Nuvation Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvation Bio has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Nuvation Bio has recently increased by 17.24%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nuvation Bio has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Nuvation Bio this week, compared to 4 articles on an average week.
  • Search Interest

    41 people have searched for NUVB on MarketBeat in the last 30 days. This is an increase of 156% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Nuvation Bio to their MarketBeat watchlist in the last 30 days. This is an increase of 83% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuvation Bio insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $50,000.00 in company stock.

  • Percentage Held by Insiders

    29.93% of the stock of Nuvation Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    61.67% of the stock of Nuvation Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nuvation Bio's insider trading history.
Receive NUVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvation Bio and its competitors with MarketBeat's FREE daily newsletter.

NUVB Stock News Headlines

Analysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.17
[ATTENTION] This Crypto Rocket Is About Launch…
Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.
Founder of Nuvation Bio David Hung Buys More Stock
See More Headlines

NUVB Stock Analysis - Frequently Asked Questions

Nuvation Bio's stock was trading at $2.66 on January 1st, 2025. Since then, NUVB shares have decreased by 16.7% and is now trading at $2.2150.

Nuvation Bio Inc. (NYSE:NUVB) released its earnings results on Wednesday, May, 7th. The company reported ($0.16) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.16). The firm had revenue of $3.08 million for the quarter, compared to analyst estimates of $0.42 million. Nuvation Bio had a negative trailing twelve-month return on equity of 44.14% and a negative net margin of 5,534.21%.
Read the conference call transcript
.

Nuvation Bio's top institutional investors include Crowley Wealth Management Inc. (0.03%), Pallas Capital Advisors LLC (0.01%), Wealth Enhancement Advisory Services LLC (0.01%) and Assenagon Asset Management S.A. (0.01%). Insiders that own company stock include David Hung, Oleg Nodelman, Xiangmin Cui, Kim D Blickenstaff, Robert Mashal and Dongfang Liu.
View institutional ownership trends
.

Shares of NUVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuvation Bio investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/07/2025
Today
7/16/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NUVB
CIK
1811063
Fax
N/A
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$5.00
Potential Upside/Downside
+215.0%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$567.94 million
Net Margins
-5,534.21%
Pretax Margin
-5,534.21%
Return on Equity
-44.14%
Return on Assets
-32.97%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.01
Quick Ratio
9.01

Sales & Book Value

Annual Sales
$7.87 million
Price / Sales
98.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.37 per share
Price / Book
1.66

Miscellaneous

Outstanding Shares
340,260,000
Free Float
238,422,000
Market Cap
$774.09 million
Optionable
Optionable
Beta
1.33
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:NUVB) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners